NCT04717102View on ClinicalTrials.gov

Evaluating the Use of 0.5 and 0.75 MAC Desflurane in Patients Undergoing Spinal Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

April 14, 2021

Primary Completion Date

March 27, 2024

Study Completion Date

March 27, 2024

Conditions
Anesthesia
Interventions
DRUG

0.5 MAC desflurane

Following induction of anesthesia by propofol, the patients will be maintained on 0.5 MAC desflurane with remifentanil infusion during spinal surgery.

DRUG

0.75 MAC desflurane

Following induction of anesthesia by propofol, the patients will be maintained on 0.75 MAC desflurane with remifentanil infusion during spinal surgery.

DRUG

1.0 MAC desflurane

On completion of the neuromonitoring phase of surgery, the patients will be maintained on 1.0 MAC desflurane with remifentanil infusion.

Trial Locations (1)

529889

Changi General Hospital, Singapore

All Listed Sponsors
lead

Changi General Hospital

OTHER